Return on Investment

Xcellerex has developed an interactive ROI tool to assist customers in evaluating the economic impacts of utilizing the XDR bioreactor.

Biopharm customer analyses versus conventional stainless steel systems indicate that Xcellerex XDR™ GMP Bioreactors will:

Reduce installed-system capital investment by up to 75% (more than $1 million)

Cut annual operating costs by 35% (up to $900,000)

Accelerate time to start-up by more than 10 months, reducing investment risk and speeding time to market

For a free XDR Economic Impact Assessment, please contact.